Shattuck Labs, Inc. (STTK) Stock Grade

About Shattuck Labs, Inc.'s fundamentals

Shattuck Labs is a biotechnology company with a market capitalization of $254.0 million that reported severe financial deterioration in its latest period, with revenue declining 82.5% year-over-year and a net loss that resulted in a negative net margin of -4880.9%. The company does not pay a dividend and lacks meaningful profitability metrics such as a positive P/E ratio or return on equity. These metrics indicate the company is in a significant financial struggle, likely reflecting challenges in its product development pipeline or commercialization efforts typical of early-stage biotech firms.